Skip to main content
NCBI home page
Proceedings of the National Academy of Sciences of the United States of America logoLink to Proceedings of the National Academy of Sciences of the United States of America
. 1979 Oct;76(10):5377–5381. doi: 10.1073/pnas.76.10.5377

β-Endorphin: Analgesic and hormonal effects in humans

Kathleen M Foley *, Ione A Kourides *, Charles E Inturrisi *, Robert F Kaiko *, Charles G Zaroulis *, Jerome B Posner *, Raymond W Houde *, Choh Hao Li †
PMCID: PMC413146  PMID: 291954

Abstract

The pharmacokinetics and the hormonal, analgesic, and behavioral effects of several doses of human β-endorphin were evaluated after intravenous administration to three patients and intracerebroventricular administration to one patient with pain caused by cancer. These effects were compared to the hormonal effects of intravenously administered morphine sulfate in two patients and an enkephalin analog in two baboons. The mean terminal half-life after intravenous administration of 5 or 10 mg of human β-endorphin to three patients was 37 min; the mean volume of distribution was 178 ml/kg, and the metabolic clearance rate was 3.2 (ml/min)/kg. The half-life of β-endorphin in cerebrospinal fluid after intracerebroventricular administration was 93 min, and the volume of distribution was 0.74 ml/kg. A rapid rise in plasma prolactin followed both intravenous and intracerebroventricular β-endorphin. Intravenous administration did not affect plasma growth hormone, but intracerebroventricular administration suppressed plasma growth hormone. No significant change in plasma growth hormone was noted after intravenous administration of morphine to humans, but plasma growth hormone decreased in one baboon after administration of the enkephalin analog. β-Endorphin-stimulated release of prolactin occurred at doses lower than those required to produce analgesic and other behavioral effects. When both hormonal and analgesic effects were observed (after 7.5 mg were given intracerebroventricularly), the onset of the hormonal response slightly preceded the analgesic and behavioral responses. These studies suggest that the hormonal effects of β-endorphin are species dependent and are similar to those of morphine. Hormonal and analgesic effects of β-endorphin appear to result from the activation of opiate receptors that differ in their locations and characteristics.

Keywords: metabolic clearance rate, prolactin, growth hormone, enkephalin analog, baboons

Full text

PDF
5377

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bigos S. T., Ridgway E. C., Kourides I. A., Maloof F. Spectrum of pituitary alterations with mild and severe thyroid impairment. J Clin Endocrinol Metab. 1978 Feb;46(2):317–325. doi: 10.1210/jcem-46-2-317. [DOI] [PubMed] [Google Scholar]
  2. Bloom F., Segal D., Ling N., Guillemin R. Endorphins: profound behavioral effects in rats suggest new etiological factors in mental illness. Science. 1976 Nov 5;194(4265):630–632. doi: 10.1126/science.185694. [DOI] [PubMed] [Google Scholar]
  3. Catlin D. H., George R., Li C. H. Beta-endorphin: pharmacologic and behavioral activity in cats after low intravenous doses. Life Sci. 1978 Nov 20;23(21):2147–2154. doi: 10.1016/0024-3205(78)90188-1. [DOI] [PubMed] [Google Scholar]
  4. Chihara K., Arimura A., Coy D. H., Schally A. V. Studies on the interaction of endorphins, substance P. and endogenous somatostatin in growth hormone and prolactin release in rats. Endocrinology. 1978 Jan;102(1):281–290. doi: 10.1210/endo-102-1-281. [DOI] [PubMed] [Google Scholar]
  5. Dupont A., Cusan L., Garon M., Labrie F., Li C. H. Beta-endorphin: stimulation of growth hormone release in vivo. Proc Natl Acad Sci U S A. 1977 Jan;74(1):358–359. doi: 10.1073/pnas.74.1.358. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Folstein M. F., Luria R. Reliability, validity, and clinical application of the Visual Analogue Mood Scale. Psychol Med. 1973 Nov;3(4):479–486. doi: 10.1017/s0033291700054283. [DOI] [PubMed] [Google Scholar]
  7. George J. M., Reier C. E., Lanese R. R., Rower M. Morphine anesthesia blocks cortisol and growth hormone response to surgical stress in humans. J Clin Endocrinol Metab. 1974 May;38(5):736–741. doi: 10.1210/jcem-38-5-736. [DOI] [PubMed] [Google Scholar]
  8. Guillemin R., Vargo T., Rossier J., Minick S., Ling N., Rivier C., Vale W., Bloom F. beta-Endorphin and adrenocorticotropin are selected concomitantly by the pituitary gland. Science. 1977 Sep 30;197(4311):1367–1369. doi: 10.1126/science.197601. [DOI] [PubMed] [Google Scholar]
  9. Hosobuchi Y., Li C. H. The analgesic activity of human beta-endorphin in man (1,2,3). Commun Psychopharmacol. 1978;2(1):33–37. [PubMed] [Google Scholar]
  10. Hosobuchi Y., Rossier J., Bloom F. E., Guillemin R. Stimulation of human periaqueductal gray for pain relief increases immunoreactive beta-endorphin in ventricular fluid. Science. 1979 Jan 19;203(4377):279–281. doi: 10.1126/science.83674. [DOI] [PubMed] [Google Scholar]
  11. Kourides I. A., Weintraub B. D., Rosen S. W., Ridgway E. C., Kliman B., Maloof F. Secretion of alpha subunit of glycoprotein hormones by pituitary adenomas. J Clin Endocrinol Metab. 1976 Jul;43(1):97–106. doi: 10.1210/jcem-43-1-97. [DOI] [PubMed] [Google Scholar]
  12. Li C. H., Yamashiro D., Tseng L. F., Loh H. H. Synthesis and analgesic activity of human beta-endorphin. J Med Chem. 1977 Mar;20(3):325–328. doi: 10.1021/jm00213a001. [DOI] [PubMed] [Google Scholar]
  13. Lien E. L., Clark D. E., McGregor W. H. Stimulation of growth hormone and prolactin release by a potent enkephalin analog. FEBS Lett. 1978 Apr 15;88(2):208–210. doi: 10.1016/0014-5793(78)80175-6. [DOI] [PubMed] [Google Scholar]
  14. Liotta A. S., Li C. H., Schussler G. C., Krieger D. T. Comparative metabolic clearance rate, volume of distribution and plasma half-life of human beta-lipotropin and ACTH. Life Sci. 1978 Dec 4;23(23):2323–2330. doi: 10.1016/0024-3205(78)90198-4. [DOI] [PubMed] [Google Scholar]
  15. Loh H. H., Tseng L. F., Wei E., Li C. H. beta-endorphin is a potent analgesic agent. Proc Natl Acad Sci U S A. 1976 Aug;73(8):2895–2898. doi: 10.1073/pnas.73.8.2895. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. MARQUARDT P., SCHUMACHER H., VOGG G. Die chemische Konstitution des blutdrucksenkenden Faktors in der Kartoffel. Arzneimittelforschung. 1952 Jul;2(7):301–304. [PubMed] [Google Scholar]
  17. Reed J. L., Ghodse A. H. Oral glucose tolerance and hormonal response in heroin-dependent males. Br Med J. 1973 Jun 9;2(5866):582–585. doi: 10.1136/bmj.2.5866.582. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rivier C., Vale W., Ling N., Brown M., Guillemin R. Stimulation in vivo of the secretion of prolactin and growth hormone by beta-endorphin. Endocrinology. 1977 Jan;100(1):238–241. doi: 10.1210/endo-100-1-238. [DOI] [PubMed] [Google Scholar]
  19. Shapiro W. R., Young D. F., Mehta B. M. Methotrexate: distribution in cerebrospinal fluid after intravenous, ventricular and lumbar injections. N Engl J Med. 1975 Jul 24;293(4):161–166. doi: 10.1056/NEJM197507242930402. [DOI] [PubMed] [Google Scholar]
  20. Spector S. Quantitative determination of morphine in serum by radioimmunoassay. J Pharmacol Exp Ther. 1971 Aug;178(2):253–258. [PubMed] [Google Scholar]
  21. Stubbs W. A., Delitala G., Jones A., Jeffcoate W. J., Edwards C. R., Ratter S. J., Besser G. M., Bloom S. R., Alberti K. G. Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet. 1978 Dec 9;2(8102):1225–1227. doi: 10.1016/s0140-6736(78)92100-1. [DOI] [PubMed] [Google Scholar]
  22. Tolis G., Hickey J., Guyda H. Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man. J Clin Endocrinol Metab. 1975 Oct;41(4):797–800. doi: 10.1210/jcem-41-4-797. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

RESOURCES